What additional test should be ordered for a pediatric patient with uncontrolled asthma, failure to thrive, and foul-smelling stools to rule out underlying conditions such as cystic fibrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sweat Chloride Test for Suspected Cystic Fibrosis

Yes, order a sweat chloride test immediately—this patient's clinical triad of uncontrolled asthma, failure to thrive, and foul-smelling stools (steatorrhea) is highly suggestive of cystic fibrosis (CF), and the sweat chloride test is the gold standard diagnostic test for CF. 1, 2

Clinical Reasoning

This presentation represents a classic CF phenotype that requires urgent diagnostic evaluation:

  • Failure to thrive is present in 90% of CF patients at diagnosis 2
  • Steatorrhea (foul-smelling, greasy stools indicating pancreatic insufficiency) occurs in 69% of CF patients at diagnosis 2
  • Recurrent/uncontrolled respiratory symptoms mimicking asthma are found in 71% of CF patients at diagnosis 2

The combination of these three findings should immediately trigger CF evaluation, as CF commonly masquerades as difficult-to-control asthma in children. 2

Diagnostic Test Specifications

Sweat Chloride Test Details

  • Diagnostic threshold: Sweat chloride ≥60 mmol/L confirms CF diagnosis 1, 3
  • Normal values: <60 mmol/L rules out CF 1
  • Test method: Quantitative pilocarpine iontophoresis (Gibson and Cooke technique) is the gold standard 1, 3
  • Confirmation requirement: Two documented positive sweat chloride tests are needed for definitive diagnosis 2

Test Performance Characteristics

The sweat chloride test demonstrates excellent diagnostic accuracy:

  • Sensitivity: 83.3% when using ≥90 mmol/L cutoff 1
  • Specificity: 99.7% 1
  • Positive predictive value: 90.9% 1
  • Negative predictive value: 99.4% 1

Important Clinical Caveats

Borderline Results Require Caution

  • Borderline sweat chloride values (40-60 mmol/L) can occur in other conditions, including severe combined immunodeficiency (SCID) with hypogammaglobulinemia 4
  • If sweat chloride is borderline elevated, consider immune deficiency workup alongside CF genetic testing 4
  • In adults, sweat chloride >70 mmol/L always discriminates CF from non-CF conditions, whereas sodium values alone may be falsely elevated 3

Additional Diagnostic Considerations

  • CF genetic mutation analysis should be performed if sweat chloride is positive or borderline to identify specific CFTR mutations 4, 5
  • Sweat conductivity (if available) can serve as an alternative with good agreement to sweat chloride (kappa: 0.934), using cutoff of ≥90 mmol/L for diagnosis 1

Why This Test Takes Priority

CF is a life-threatening condition requiring immediate diagnosis and intervention:

  • Early diagnosis dramatically improves outcomes 2
  • Delayed diagnosis leads to progressive, irreversible lung damage 5
  • CF presents with multi-organ dysfunction requiring mutation-specific therapies that target the basic CFTR defect 5
  • The sweat chloride test provides definitive proof of CFTR dysfunction, which is required to establish CF diagnosis 5

Clinical Pitfall to Avoid

Do not dismiss this as simply "uncontrolled asthma" requiring escalation of asthma therapy. 6 The presence of failure to thrive and steatorrhea indicates systemic disease beyond isolated respiratory pathology. In regions without newborn screening, clinical suspicion and awareness are crucial for early CF diagnosis. 2

References

Research

Sweat conductivity: an accurate diagnostic test for cystic fibrosis?

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2014

Research

Clinical presentation of cystic fibrosis at the time of diagnosis: a multicenter study in a region without newborn screening.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.